Targeting regulatory T cells in cancer and autoimmunity: opposing immune microenvironments, mechanisms of clinical trial failure, and a redesign framework guided by biomarkers
Regulatory T cells (Tregs) are central regulators of immune tolerance. However, therapies targeting Tregs have not yet produced consistent clinical benefits in cancer or autoimmune disease. We propose that one long-underestimated reason is that Tregs are not static drug targets. They are dynamic immune regulatory cells that are continuously shaped by the microenvironment. In the tumor microenvironment (TME), cytokine, metabolic, and epigenetic signals usually promote Treg recruitment, metabolic adaptation, and functional stability. In autoimmune disease, these signals are more often associated with insufficient Treg numbers, unstable phenotypes, or impaired function. Based on this view, we propose a framework of opposing microenvironments. This framework shows that the functional opposition of Tregs in cancer and autoimmunity arises from a fundamental reversal of the microenvironment. We then critically reassess five therapeutic strategies in the two disease settings, including interleukin-2 (IL-2) signaling, co-signaling checkpoints, metabolic regulation, epigenetic reprogramming, and Treg cell therapy. We also summarize representative failed or stalled clinical trials as repeated patterns of failure. Finally, we propose a candidate redesign framework guided by biomarkers. This framework integrates patient stratification, therapeutic direction, dose windows, treatment sequence, efficacy monitoring, and safety monitoring. It may help move Treg therapy from a molecular-targeted approach to a precision immune intervention guided by the microenvironment.
Authors
- Yuehong Hu
- 姜寒雪
- Hongliang Rui (ORCID: https://orcid.org/0000-0002-7584-9610)
- Baoli Liu
- Wenbin Liu (ORCID: https://orcid.org/0000-0002-5713-9922)
- Haoran Dai
- Qihan Zhao (ORCID: https://orcid.org/0009-0000-6708-266X)
- Xiaoyu Cui
- Yadi Wu
Institutions
- Capital Medical University (CN)
- Beijing Hospital of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Journal of Translational Medicine
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1186/s12967-026-09230-7
- Primary Topic
- T-cell and B-cell Immunology
- Type
- article
- Field-Weighted Citation Impact
- 0.00